Ensayos clínicos

8.676 ensayos encontrados

CompletadoFase 3ClinicalTrials.gov

Administración a largo plazo de manitol inhalado en fibrosis quística - Ensayo clínico de seguridad y eficacia en sujetos adultos con fibrosis quística

IntervencionalInicio: 1 de sept de 2014ID: NCT02134353

CompletadoFase 3ClinicalTrials.gov

Estudio de fase 3, aleatorizado y abierto de brigatinib (ALUNBRIG®) frente a alectinib (ALECENSA®) en pacientes con cáncer de pulmón de células no pequeñas avanzado con quinasa de linfoma anaplásico positiva que han progresado con crizotinib (XALKORI®)

IntervencionalInicio: 19 de abr de 2019ID: NCT03596866

CompletadoFase 2ClinicalTrials.gov

Estudio multicéntrico, aleatorizado, doble ciego, doble simulación, con control activo, de grupos paralelos, para comparar la seguridad de rivaroxabán versus ácido acetilsalicílico en adición a terapia con clopidogrel o ticagrelor en sujetos con síndrome coronario agudo.

IntervencionalInicio: 20 de abr de 2015ID: NCT02293395

CompletadoFase 4ClinicalTrials.gov

A Randomised, Double-Blind Placebo Controlled Trial Comparing the Effect of Intravenous Ferric Carboxymaltose on Hospitalisations and Mortality in Iron Deficient Patients Admitted for Acute Heart Failure (Affirm-AHF)

IntervencionalInicio: 3 de abr de 2017ID: NCT02937454

CompletadoFase 3ClinicalTrials.gov

A Randomized Phase III, Double-Blind, Placebo-Controlled Multicenter Trial of Everolimus in Combination With Trastuzumab and Paclitaxel, as First Line Therapy in Women With HER2 Positive Locally Advanced or Metastatic Breast Cancer

IntervencionalInicio: 10 de sept de 2009ID: NCT00876395

CompletadoFase 3ClinicalTrials.gov

An Open- Label Rollover Study for Subjects With Schizophrenia Completing ABILIFY® (Aripiprazole) Clinical Study 31-03-241

IntervencionalInicio: 1 de abr de 2006ID: NCT01001702

CompletadoClinicalTrials.gov

Intensity Lenses Post Operation Standard of Care Visits - Data Collection.

ObservacionalInicio: 13 de jul de 2023ID: NCT06220331

CompletadoFase 3ClinicalTrials.gov

A Phase III, Randomized, Multicenter, Double-Blind, Double Dummy, Parallel Group, Comparative Study to Determine the Efficacy, Safety, and Tolerability of Ceftazidime Avibactam (CAZ-AVI, Formerly CAZ104) Versus Doripenem Followed by Appropriate Oral Therapy in the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis, With a Gram Negative Pathogen in Hospitalized Adults

IntervencionalInicio: 1 de oct de 2012ID: NCT01599806

CompletadoFase 3ClinicalTrials.gov

Randomized, OpenLabel, Phase 3 Trial of Nivolumab Plus Ipilimumab or Nivolumab Plus Platinum Doublet Chemotherapy Versus Platinum Doublet Chemotherapy in Early Stage NSCLC

IntervencionalInicio: 4 de mar de 2017ID: NCT02998528

CompletadoFase 3ClinicalTrials.gov

A Multinational, Randomized, Double Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of AVE5026 in the Prevention of Venous Thromboembolism (VTE) in Cancer Patients at High Risk for VTE and Who Are Undergoing Chemotherapy

IntervencionalInicio: 1 de jun de 2008ID: NCT00694382

CompletadoClinicalTrials.gov

Proportional Assist Ventilation for Minimizing the Duration of Mechanical Ventilation: The PROMIZING Study

IntervencionalInicio: 14 de sept de 2016ID: NCT02447692

CompletadoFase 3ClinicalTrials.gov

A Phase 3, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Oral Lefamulin (BC 3781) Versus Oral Moxifloxacin in Adults With Community-Acquired Bacterial Pneumonia

IntervencionalInicio: 1 de ago de 2016ID: NCT02813694

CompletadoClinicalTrials.gov

Doubling Outcomes by Lung Cancer Early Diagnosis: An Observational, Study to Collect Real-world Evidence (RWE) on the Management of Pulmonary Nodules Across Latin-America

ObservacionalInicio: 30 de dic de 2021ID: NCT05091437

ReclutandoFase 3ClinicalTrials.gov

Ensayo clínico aleatorizado, doble ciego, controlado con placebo con extensión abierta para evaluar la farmacocinética, seguridad y eficacia de comprimidos de empagliflozina en pacientes pediátricos con enfermedad renal crónica (EMPA-KIDNEY® Kids)

IntervencionalInicio: 9 de dic de 2025ID: NCT07107945

TerminadoFase 2ClinicalTrials.gov

Hyperbaric Oxygen as an Adjuvant Treatment for Patients With Covid-19 Severe Hypoxemia

IntervencionalInicio: 6 de jul de 2020ID: NCT04477954

CompletadoFase 3ClinicalTrials.gov

A 26-week Treatment, Randomized, Multicenter, Double-blind, Double-dummy, Parallel-group Study to Assess the Safety of Indacaterol (300 and 600 µg o.d.) in Patients With Moderate to Severe Persistent Asthma, Using Salmeterol (50 µg b.i.d.) as an Active Control

IntervencionalInicio: 1 de sept de 2007ID: NCT00529529

TerminadoFase 3ClinicalTrials.gov

An Open Label Study of the Safety, Tolerability and Effect on Hemoglobin Levels of Once-monthly Subcutaneous Mircera in Predialysis Patients With Chronic Renal Anemia Not Currently Treated With ESA.

IntervencionalInicio: 1 de abr de 2009ID: NCT00680563

TerminadoClinicalTrials.gov

AO Multicenter Intervention Trial to Evaluate the Impact of a Bundle of Measures for the Prevention of Surgical Site Infection in Fracture Patients

IntervencionalInicio: 6 de dic de 2019ID: NCT03380273

Activo, no reclutaFase 3ClinicalTrials.gov

Estudio controlado, aleatorizado, doble ciego, de fase 2/3, de zanzalintinib (XL092) en combinación con pembrolizumab frente a pembrolizumab en monoterapia como tratamiento de primera línea en sujetos con carcinoma de células escamosas de cabeza y cuello recurrente o metastásico con expresión positiva de PD-L1

IntervencionalInicio: 7 de jun de 2024ID: NCT06082167

CompletadoFase 3ClinicalTrials.gov

A Phase 3 Trial of ALIMTA (LY231514, Pemetrexed) Plus GEMZAR Versus GEMZAR in Patients With Unresectable or Metastatic Cancer of the Pancreas.

IntervencionalID: NCT00035035